Not Signed In -
Insulin glargine |
insulin glargine [rDNA origin]; Lantus |
Clinical Trial: Safety and Efficacy of Insulin Detemir plus Insulin Aspart vs. Insulin Glargine plus Insulin Aspart as Mealtime Insulin in Type I Diabetes
This study is no longer recruiting patients.
|
Purpose
The purpose of this study is to test whether insulin detemir is a safe and at least as effective alternative to insulin glargine for the control of blood glucose in basal/bolus therapy in patients with type I diabetes.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Diabetes Mellitus, Type I | Drug: insulin detemir Drug: Lantus (insulin glargine) Drug: Novolog (insulin aspart) | Phase III |
MedlinePlus related topics: Juvenile Diabetes
Study Type: Interventional
Study Design: Treatment
Further Study Details:
Expected Total Enrollment: 435
Study start: October 2004; Study completion: March 2006
Last follow-up: January 2006; Data entry closure: February 2006
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
- Type I diabetics age 18 or older that have had diabetes for at least 12 months.
Location Information
California
San Diego, California, 92161, United States
Huntington Beach, California, 92646, United States
San Francisco, California, 94143, United States
Inglewood, California, 90301, United States
Irvine, California, 92618, United States
La Jolla, California, 92037, United States
Anaheim, California, 92801, United States
Florida
Melbourne, Florida, 32901, United States
Vero Beach, Florida, 32960, United States
Hollywood, Florida, 33021, United States
Tampa, Florida, 33613, United States
Winter Park, Florida, 32789, United States
Georgia
Atlanta, Georgia, 30309, United States
Idaho
Idaho Falls, Idaho, 83404, United States
Illinois
Chicago, Illinois, 60607, United States
Kansas
Topeka, Kansas, 66606, United States
Michigan
Detroit, Michigan, 48235, United States
Missouri
St. Louis, Missouri, 63110, United States
Nebraska
Omaha, Nebraska, 68131, United States
Nevada
Las Vegas, Nevada, 89109, United States
New Jersey
Brick, New Jersey, 08724, United States
Berlin, New Jersey, 08009, United States
North Carolina
Asheville, North Carolina, 28801, United States
Pennsylvania
Philadelphia, Pennsylvania, 19107, United States
Texas
Dallas, Texas, 75235, United States
Houston, Texas, 77030, United States
Dallas, Texas, 75390-8858, United States
San Antonio, Texas, 78229, United States
More Information
Study ID Numbers: NN304-1430
Record last reviewed: March 2005
Last Updated: March 18, 2005
Record first received: October 29, 2004
ClinicalTrials.gov Identifier: NCT00095082
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: March 2005
Last Updated: March 18, 2005
Record first received: October 29, 2004
ClinicalTrials.gov Identifier: NCT00095082
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
email this page
print this page
bookmark this page
feedback on this page
